Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Faster-acting insulin aspart versus NovoRapid with insulin degludec in children and adolescents with type 1 diabetes
2014-002568-33Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of human insulin in diabetes mellitus type 1 (T1D) (3 arms), sponsored by Novo Nordisk. Primary endpoint: Change from baseline in HbA1c. Started Feb 2016; status: completed.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2014-002568-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002568-33.